Replies to post #239857 on Biotech Values

[DewDiligence]

THRX—(-69%/AH)—discontinues lead program due to toxicity:

https://www.prnewswire.com/news-releases/theseus-pharmaceuticals-to-discontinue-enrollment-in-phase-12-study-and-terminate-development-of-the-630-in-patients-with-gist-301877076.html